FABP4 Downregulated by FOS Alleviates Palmitic Acid-induced Endothelial Cell Dysfunction Via Inactivating ERK/STAT-1

Mengting Ruan1, Jin Zhang2

  • 1Department of Obstetrics, Zhuji People's Hospital of Zhejiang Province, Zhuji, Zhejiang, P.R. China.

Insights

Fatty acid-binding protein 4 (FABP4) is elevated in preeclampsia (PE). FABP4 interference protects against palmitic acid-induced endothelial cell dysfunction by inhibiting the ERK/STAT-1 pathway, potentially mediated by FOS.

Area of Science:

  • Reproductive Biology
  • Molecular Medicine
  • Cellular Biology

Background:

  • Preeclampsia (PE) is a serious pregnancy complication characterized by hypertension and organ damage.
  • The underlying mechanisms of PE pathogenesis remain incompletely understood, necessitating further investigation into key molecular players.
  • Fatty acid-binding protein 4 (FABP4) has been implicated in metabolic disorders, but its specific role in PE is unclear.

Purpose of the Study:

  • To elucidate the role of FABP4 in the pathogenesis of preeclampsia (PE).
  • To investigate the underlying molecular mechanisms by which FABP4 influences endothelial cell function in PE.
  • To explore the potential involvement of the FOS protein in regulating FABP4 activity and its downstream signaling.

Main Methods:

  • Quantification of FABP4 expression in blood and placental tissues from PE patients and controls using RT-qPCR.
  • In vitro studies using human umbilical vein endothelial cells (HUVECs) treated with palmitic acid (PA) to mimic PE conditions.
  • Manipulation of FABP4 and FOS expression via transfection (sh-FABP4, sh-FOS, Ov-FOS) and assessment of cell viability, apoptosis (TUNEL assay), migration, invasion (wound healing, Transwell assays), and angiogenesis (tube formation assay).
  • Analysis of apoptosis-related proteins and the ERK/STAT-1 signaling pathway via Western blotting.
  • Luciferase reporter and ChIP assays to determine FABP4 promoter activity and FOS binding to FABP4.

Main Results:

  • FABP4 expression was significantly increased in the blood and placental tissues of PE patients and in PA-treated HUVECs.
  • Interference with FABP4 expression reduced apoptosis and enhanced migration, invasion, and angiogenesis in PA-induced HUVECs by inactivating the ERK/STAT-1 signaling pathway.
  • FOS was found to reduce FABP4 activity and inhibit the FABP4/ERK/STAT-1 signaling pathway, suggesting a protective role.

Conclusions:

  • FABP4 plays a crucial role in the pathogenesis of preeclampsia by promoting endothelial cell dysfunction.
  • FABP4 exacerbates PA-induced endothelial cell injury via activation of the ERK/STAT-1 signaling pathway.
  • FOS may protect against PA-induced endothelial cell dysfunction by inhibiting the FABP4/ERK/STAT-1 pathway, highlighting a potential therapeutic target for PE.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
33